The pharmaceutical industry is aggressively evolving, with growing demand for high-efficacy Active Pharmaceutical Ingredients (APIs). Dulaglutide, a diabetes drug, stands as copyrightple of this trend. To address this demand, US-based manufacturing services are emerging. These companies offer a wide-ranging suite of capabilities, from research and